Fig. 6
From: Significance of OCT3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia
Kaplan-Meier curve for the impact of SOX2 expression and OCT3/4 expression on OS and DFS of AML patients. A, B Patients with low SOX2 expression (< 21.7%) and low OCT3/4 expression (< 1.55%) had longer cumulative OS survival as compared to those with high expression (P < 0.001), and (P = 0.022) respectively). C, D Patients with low SOX2 expression (< 21.7%) and OCTA3/4 had longer cumulative DFS as compared to those with high expression (P = 0.003, P = < 0.001 respectively)